Dr. Lutz Hegemann is the President of Global Health and Swiss Country Affairs at Novartis.  The Global Health unit focuses on transforming healthcare in low- and middle-income countries by broadening access to innovative medicines.  This includes programmes targeting malaria, neglected tropical diseases, and select non-communicable diseases such as sickle cell disease and cardiovascular disease.  He oversees Novartis’ presence in sub-Saharan Africa.  

Lutz also represents the company both at home in Switzerland and internationally, building strategic partnerships across public and private sectors to advance inclusive global health innovation.

Lutz joined Novartis in 2005 in the Consumer Health Division and has held roles across Research & Development, Commercialisation, General Management, and Corporate Affairs.  He began his career as a public health physician and scientist.  Lutz is a Fellow of the Royal Society for Tropical Medicine & Hygiene and serves on several boards, including the Swiss Tropical and Public Health Institute, PATH and the World Heart Federation.